| Main topic | Clinics |
|---|---|
|
Subtopic |
BNCT – Clinics |
|
Subtopic |
Challenging clinical scenario: Why or why not particle therapy |
|
Subtopic |
Clinical implementation of adaptive particle therapy |
|
Subtopic |
Combined particle therapy with novel systemic therapy: efficacy and toxicities |
|
Subtopic |
Comparative effectiveness and cost-effectives analysis |
|
Subtopic |
General clinical results and patient reported outcome |
|
Subtopic |
LET and variable RBE based particle therapy |
|
Subtopic |
Long-term complications and image changes after particle therapy |
|
Subtopic |
Novel treatment strategies using particle therapy |
|
Subtopic |
Ocular treatment – Clinics aspects |
|
Subtopic |
Particle therapy -based stereotactic radiotherapy and hypo-fractionated radiotherapy |
|
Subtopic |
Particle therapy-based re-irradiation |
| Main topic | Physics |
|---|---|
|
Subtopic |
Beam delivery and nozzle design |
|
Subtopic |
BNCT – Physics |
|
Subtopic |
Dosimetry |
|
Subtopic |
Imaging |
|
Subtopic |
Motion management and adaptive therapy |
|
Subtopic |
New approaches (e.g. ultra-high dose rate, spatially fractionated therapy) |
|
Subtopic |
Ocular treatment – Physics aspects |
|
Subtopic |
Outcome modelling |
|
Subtopic |
Quality assurance |
|
Subtopic |
Treatment planning – algorithms and methods |
|
Subtopic |
Treatment planning – applications |
| Main topic | Biology |
|---|---|
|
Subtopic |
Biomarkers of CPRT response |
|
Subtopic |
Biology of Spatial, Temporal and Dose Fractionation |
|
Subtopic |
BNCT-Biology |
|
Subtopic |
Hypoxia and CPRT |
|
Subtopic |
Immunomodulatory effects of CPRT |
|
Subtopic |
Integrating biology in treatment planning: RBE and beyond |
|
Subtopic |
Mathematical modeling & simulations of charged particle radiotherapy |
|
Subtopic |
Molecular and cellular effects of CPRT vs XRT |
|
Subtopic |
Targeted agents with CPRT |